Epilepsy trials recruiting in Missouri

All Epilepsy trials nationally

Cities in Missouri

Recruiting trials in Missouri

• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
  NCT06132893 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Missouri: St Louis
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
  NCT05667142 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Missouri: St Louis
• Amygdala Memory Enhancement
  NCT05065450 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Missouri: St Louis
• An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
  NCT06908356 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Missouri: Chesterfield
• Baker Gordon Syndrome Natural History Study
  NCT06399952 · Phase: Not specified · Ages: 0 Years to 99 Years · Sex: All (male and female) · Missouri: Columbia
• Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
  NCT05374824 · Phase: Not specified · Ages: Up to 26 Years · Sex: All (male and female) · Missouri: St Louis
• Diagnosing Epilepsy To EffeCT Change
  NCT07110337 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Missouri: St Louis
• Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
  NCT07110454 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · Missouri: St Louis
• Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
  NCT05219617 · Phase: Phase 3 · Ages: 4 Years to 55 Years · Sex: All (male and female) · Missouri: Columbia
• Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)
  NCT07329257 · Phase: Not specified · Ages: Up to 99 Years · Sex: All (male and female) · Missouri: Columbia
• Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
  NCT05104983 · Phase: Phase 2 · Ages: 1 Day to 6 Months · Sex: All (male and female) · Missouri: St Louis
• Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
  NCT05135091 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Missouri: St Louis